These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
86 related items for PubMed ID: 18575000
21. Insulin requirement after one year of insulin therapy in type 2 diabetic patients dependent on fasting C-peptide. Biesenbach G, Bodlaj G, Pieringer H, Raml A. Neth J Med; 2008 Jun; 66(6):259-60. PubMed ID: 18689911 [No Abstract] [Full Text] [Related]
22. JAMA patient page. Starting insulin treatment for diabetes. Jin J. JAMA; 2014 Jun 11; 311(22):2347. PubMed ID: 24915279 [No Abstract] [Full Text] [Related]
23. [Blood pressure and type 2 diabetes mellitus: impact of the insulin therapy]. Dakhli S, Lamine S, Lamine F, Trabelsi N, Aouididi F, Zouaoui C, Mami FB, Achour A. Tunis Med; 2007 Nov 11; 85(11):945-50. PubMed ID: 19166146 [Abstract] [Full Text] [Related]
25. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients]. Li M, Zhou J, Bo YQ, Lu W, Jia WP, Xiang KS. Zhonghua Yi Xue Za Zhi; 2008 Jun 24; 88(24):1679-82. PubMed ID: 19024537 [Abstract] [Full Text] [Related]
26. How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus? Koenen C. Nat Clin Pract Endocrinol Metab; 2008 Oct 24; 4(10):E1. PubMed ID: 18806804 [No Abstract] [Full Text] [Related]
27. [Overweight in diabetes--what is the best treatment?]. Birkeland KI. Tidsskr Nor Laegeforen; 2008 Feb 14; 128(4):445-6. PubMed ID: 18309536 [No Abstract] [Full Text] [Related]
29. Thrice-daily biphasic insulin aspart 30 may be another therapeutic option for Chinese patients with type 2 diabetes inadequately controlled with oral antidiabetic agents. Yang WY, Ji QH, Zhu DL, Yang JK, Chen LL, Liu ZM, Yu DM, Yan L. Chin Med J (Engl); 2009 Jul 20; 122(14):1704-8. PubMed ID: 19719975 [No Abstract] [Full Text] [Related]
31. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes. Khalangot M, Tronko M, Kravchenko V, Kulchinska J, Hu G. Diabetes Res Clin Pract; 2008 Oct 20; 82(1):139-47. PubMed ID: 18703252 [Abstract] [Full Text] [Related]
36. Initiating insulin in patients with type 2 diabetes. Aoki TJ, White RD. J Fam Pract; 2007 Aug 20; 56(8 Suppl Hot Topics):S12-20. PubMed ID: 18667139 [Abstract] [Full Text] [Related]
37. Risk factors associated with symptomatic hypoglycemia in type 2 diabetes mellitus patients. Durán-Nah JJ, Rodríguez-Morales A, Smitheram J, Correa-Medina C. Rev Invest Clin; 2008 Aug 20; 60(6):451-8. PubMed ID: 19378831 [Abstract] [Full Text] [Related]
38. Integrating innovative tools into the management of type 2 diabetes to improve patient self-management. Kruger DF. J Am Acad Nurse Pract; 2008 Nov 20; 20 Suppl 1():17-20. PubMed ID: 19402256 [No Abstract] [Full Text] [Related]
39. Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting. Hahr AJ, Molitch ME. Am J Ther; 2008 Nov 20; 15(6):543-50. PubMed ID: 19127139 [Abstract] [Full Text] [Related]
40. Insulin therapy in elderly patients with type 2 diabetes: the role of insulin glargine. Janka HU. Diabetes Obes Metab; 2008 Jul 20; 10 Suppl 2():35-41. PubMed ID: 18577155 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]